Skip to main content
. 2023 Oct 11;11(4):101137. doi: 10.1016/j.gendis.2023.101137

Figure 1.

Figure 1

Secondary findings (SFs) in 100 trio exome sequencing (ES). (A) Cohort description. (B) Total P/LP variants as SFs per 100 trio ES. (C) SFs and diagnosis yield per trio ES. (D) Median, minimum, maximum, and quartiles of the number of SFs per trio ES. (E) Recurrence in genes of SFs. (F) mode of inheritance in genes of SFs. (G) SFs found in the 3 lists of genes. (H) Clinical grade of SFs. (I–K) Considerations for clinical grade, respectively for high clinical impact, familial interest and low clinical impact.